The PE Ratio as of December 2024 (TTM) for Satsuma Pharmaceuticals, Inc. (STSA) is -0.55

According to Satsuma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.55. This represents a change of -64.09% compared to the average of -1.54 of the last 4 quarters.

Satsuma Pharmaceuticals, Inc. (STSA) Historical PE Ratio (quarterly & annually)

How has STSA PE Ratio performed in the past?

The mean historical PE Ratio of Satsuma Pharmaceuticals, Inc. over the last ten years is -6.67. The current -0.55 PE Ratio has changed 729.05% with respect to the historical average. Over the past ten years (40 quarters), STSA's PE Ratio was at its highest in in the December 2022 quarter at -0.33. The PE Ratio was at its lowest in in the September 2018 quarter at -18.11.

Satsuma Pharmaceuticals, Inc. (STSA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Satsuma Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Satsuma Pharmaceuticals, Inc. (STSA) Average PE Ratio

How has STSA PE Ratio performed in the past?

The current PE Ratio of Satsuma Pharmaceuticals, Inc. (STSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Satsuma Pharmaceuticals, Inc. (STSA) PE Ratio vs. Peers

How is STSA’s PE Ratio compared to its peers?

Satsuma Pharmaceuticals, Inc.’s PE Ratio is greater than ZIVO Bioscience, Inc. (-5.50), greater than Theseus Pharmaceuticals, Inc. (-6.29), greater than Erasca, Inc. (-4.56), greater than Forte Biosciences, Inc. (-1.06), less than Applied Molecular Transport Inc. (-0.43), greater than SAB Biotherapeutics, Inc. (-0.83), less than Senti Biosciences, Inc. (-0.27), less than Cingulate Inc. (-0.00), less than Bellicum Pharmaceuticals, Inc. (-0.28), greater than Hillstream BioPharma, Inc. (-0.99), greater than Kronos Bio, Inc. (-0.67), greater than Cyclerion Therapeutics, Inc. (-1.57), greater than Larimar Therapeutics, Inc. (-3.72), less than Addex Therapeutics Ltd (1.05), greater than Achilles Therapeutics plc (-0.69), greater than Assembly Biosciences, Inc. (-2.29), less than CytomX Therapeutics, Inc. (6.58), greater than Instil Bio, Inc. (-1.89), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than PMV Pharmaceuticals, Inc. (-1.47), less than Eliem Therapeutics, Inc. (0), less than MediciNova, Inc. (-0.04), greater than Pharvaris N.V. (-7.33), greater than PepGen Inc. (-1.51),

Build a custom stock screener for Satsuma Pharmaceuticals, Inc. (STSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Satsuma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Satsuma Pharmaceuticals, Inc. (STSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Satsuma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.